Judge Will Hold Hearing Wednesday in Case That Could Block Abortion Pill Nationwide
The FDA also recently voiced concerns over the safety of abortion-by-mail for mothers as demand for chemical abortion pills surged following the Supreme Court’s Dobbs decision overturning Roe v. Wade in June 2022.
A federal judge in Texas has requested a hearing in a case challenging the Food and Drug Administration’s (FDA) approval of the abortion drug mifepristone.
As reported by CatholicVote, the Alliance Defending Freedom (ADF) sued the FDA in November 2022 on behalf of the Alliance for Hippocratic Medicine, the Catholic Medical Association, and others. The suit contends that: ---More...
View Comments
LifeNews.com is an independent news agency devoted to reporting news that affects the pro-life community. With a team of experienced journalists and bloggers, LifeNews.com reaches more than 750,000 pro-life advocates each week via our web site, email news reports, social networking outreach and weekday radio program.